At this stage, some DCs may get triggered into promoting a CD8+ T cell response, but with the lack of any strong novel antigen (the KLN205 tumors are rather poorly immunogenic), a weak specific tumor response could be triggered that would further lead to either a systemic immunization or the generation of memory T cells. The gene discussed is CD8A; the disease is neoplasm.